Urine assay detects oral semaglutide metabolites for 28 hours, researchers report
Metabolites of the absorption enhancer salcaprozate sodium stayed detectable up to seven days, offering a longer screening window for anti-doping labs.
PR
By Priya Raman · Science Reporter
Oct 1 20:00 ETSource: Drug testing and analysis
The wire
- 01A UHPLC-HRMS method reached a 0.03 ng/mL limit of detection for semaglutide metabolites U6 and U7; after a single 3 mg oral microdose they appeared at 21 hours and persisted to 28 hours.
- 02Authors frame semaglutide misuse as a risk in weight-class sports, and the method gives testing labs a validated route to screen for the oral formulation.
- 03The excretion profile comes from one healthy volunteer across 25 post-dose samples, so detection windows at therapeutic doses and across populations remain unestablished.
From the source
Read at pubmed.ncbi.nlm.nih.govDetection and Excretion Profiling of Semaglutide Use in Human Urine by UHPLC-HRMS for Anti-Doping Purpose
Drug testing and analysis · 2026 Oct 2 · Tian T, Chen X, Deng X et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42823892/
